Xeris Pharmaceuticals Inc (XERS)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $3.04B
Last updated: Nov 17, 2026 at 11:06 AM ET
Xeris Pharmaceuticals Inc (XERS) Competitors
The companies most similar to Xeris Pharmaceuticals are Eton Pharmaceuticals (ETON), Amphastar (AMPH) and BioCryst Pharmaceuticals (BCRX). Xeris Pharmaceuticals trades at 139.2x earnings, against a median of 10.7x for the 11 of these companies with a P/E. By market cap, Xeris Pharmaceuticals ranks 5th of the 13 companies on this page; Kiniksa Pharmaceuticals (KNSA) is the largest at $7.57B.
Peer Comparison
XERS's ROIC of 15.5% is above the peer median of 7.1%, and its revenue growth of 44.2% is above the median of 11.6%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Xeris Pharmaceuticals (XERS) | $3.04B | 139.2x | 8.2x | -1.8% | 15.5% | 44.2% | 0.00% |
| Eton Pharmaceuticals Inc (ETON) | $1.84B | 36.7x | 13.0x | 35.3% | 37.0% | 157.9% | 0.00% |
| Amphastar P (AMPH) | $1.25B | 10.3x | 1.7x | 13.3% | 7.9% | 8.2% | 0.00% |
| BioCryst Pharmaceuticals Inc (BCRX) | $1.96B | 4.4x | 2.0x | -37.4% | 24937.1% | 13.1% | 0.00% |
| Indivior PLC Ordinary Shares (INDV) | $4.28B | 6.6x | 2.4x | 32.8% | 109.0% | 13.4% | 0.00% |
| Perrigo Company PLC (PRGO) | $2.25B | 7.0x | 0.6x | -43.3% | -26.3% | -5.2% | 7.17% |
| Bausch Health Companies Inc (BHC) | $3.13B | 1.7x | 0.3x | -7.6% | 6.3% | 9.7% | 0.00% |
| Supernus Pharmaceuticals, Inc. (SUPN) | $1.52B | 12.7x | 2.0x | 32.8% | N/A | 13.4% | 0.00% |
| Pacira BioSciences, Inc. (PCRX) | $1.46B | 20.0x | 2.0x | 5.1% | 4.2% | -1.6% | 0.00% |
| Prestige Brand Holdings Inc (PBH) | $2.19B | 10.7x | 2.0x | 13.3% | 5.0% | 22.7% | 0.00% |
| HUTCHMED DRC (HCM) | $2.59B | N/A | 4.7x | 3.3% | -2.4% | 0.2% | 0.00% |
| Kiniksa Pharmaceuticals Ltd (KNSA) | $7.57B | 72.5x | 7.8x | 11.6% | N/A | 58.1% | 0.00% |
| Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) | $7.45B | 21.4x | 2.2x | 4.2% | 11.6% | 10.0% | 0.00% |
| Peer median | $2.22B | 10.7x | 2.0x | 8.3% | 7.1% | 11.6% | 0.00% |
Similar Companies
These are the 12 companies most similar to Xeris Pharmaceuticals, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Drug Manufacturers - Specialty & Generic.
| Company | About | Peers |
|---|---|---|
| Eton Pharmaceuticals Inc (ETON) | Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and marketing pharmaceuticals for rare diseases. | ETON competitors |
| Amphastar P (AMPH) | Amphastar Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation... | AMPH competitors |
| BioCryst Pharmaceuticals Inc (BCRX) | BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers oral and small molecule drugs. The company is headquartered in Durham, North Carolina. | BCRX competitors |
| Indivior PLC Ordinary Shares (INDV) | Indivior PLC, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence... | |
| Perrigo Company PLC (PRGO) | Perrigo Company plc is an American Irish registered manufacturer of private label over-the-counter pharmaceuticals. | PRGO competitors |
| Bausch Health Companies Inc (BHC) | Bausch Health Companies Inc. develops, manufactures and markets a range of pharmaceutical... | BHC competitors |
| Supernus Pharmaceuticals, Inc. (SUPN) | Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of diseases... | SUPN competitors |
| Pacira BioSciences, Inc. (PCRX) | Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare professionals and their patients in the United... | PCRX competitors |
| Prestige Brand Holdings Inc (PBH) | Prestige Consumer Healthcare Inc., develops, manufactures, markets, distributes and sells over-the-counter (OTC) healthcare products in the United States... | PBH competitors |
| HUTCHMED DRC (HCM) | HUTCHMED (China) Limited discovers, develops and markets targeted immunotherapies and therapies for cancer and immune diseases globally. | |
| Kiniksa Pharmaceuticals Ltd (KNSA) | Kiniksa Pharmaceuticals Ltd. (KNSA) is an innovative biopharmaceutical company focused on developing breakthrough therapies to address pressing unmet medical... | KNSA competitors |
| Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) | Amneal Pharmaceuticals, Inc. develops, licenses, manufactures, markets and distributes generic and specialty pharmaceutical products for various dosage forms... | AMRX competitors |
Frequently Asked Questions About XERS
Who are Xeris Pharmaceuticals' main competitors?
The companies most similar to Xeris Pharmaceuticals include Eton Pharmaceuticals (ETON), Amphastar (AMPH), BioCryst Pharmaceuticals (BCRX), Indivior PLC Ordinary Shares (INDV) and Perrigo Company (PRGO), listed from the closest match.
Who is Xeris Pharmaceuticals' biggest competitor?
Kiniksa Pharmaceuticals (KNSA) is the largest of the similar companies at $7.57B; Eton Pharmaceuticals (ETON) is the closest match by business profile, size, sector and industry.
How does XERS stock compare with its competitors?
XERS' P/E is 139.2x against a peer median of 10.7x; its P/S is 8.2x against a peer median of 2.0x; its net margin is -1.8% against a peer median of 8.3%.
Which of Xeris Pharmaceuticals' competitors pays a higher dividend?
Xeris Pharmaceuticals pays no dividend. Perrigo Company (PRGO) has a higher forward dividend yield; Perrigo Company (PRGO) has the highest at 7.17%.
Is Xeris Pharmaceuticals bigger than its competitors?
No. Xeris Pharmaceuticals is 5th by market cap among the 13 companies on this page; the largest is Kiniksa Pharmaceuticals (KNSA) at $7.57B.
XERS pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors